首页 | 本学科首页   官方微博 | 高级检索  
检索        

风湿性心脏瓣膜替换术后远期疗效观察
引用本文:褚衍林,李鲁,吴英渝,唐明达,张坚,顾洪斌.风湿性心脏瓣膜替换术后远期疗效观察[J].中国循环杂志,2006,21(2):140-142.
作者姓名:褚衍林  李鲁  吴英渝  唐明达  张坚  顾洪斌
作者单位:100101,北京市,中国人民解放军第306医院,心胸外科
摘    要:目的:分析风湿性心脏病瓣膜替换术后远期疗效及其影响因素。方法:我院1980年-2004年施行心脏瓣膜替换613例,早期死亡30例。术后获访495例,获访时间为2700病人年, 平均5.45病人年。结果:晚期死亡37例。晚期死亡率1.61%病人年。机械瓣和生物瓣晚期死亡率分别为1.10%和6.10%病人年,15 年生存率分别为89.3%和43.1%。结论:影响心脏瓣膜替换晚期疗效主要因素为抗凝不当、术前心功能、年龄和心房颤动。机械瓣替换术晚期死亡原因主要为抗凝有关并发症、心室颤动、细菌性心内膜炎和心力衰竭,而生物瓣膜替换术晚期死亡原因则为生物瓣衰败。

关 键 词:风湿性心脏病  晚期疗效  瓣膜替换
文章编号:1000-3614(2006)02-0140-03
修稿时间:2005年7月20日

Analysis of Long-Time Efficacy Valve Replacement for Rheumatic Heart Disease
CHU Yan-lin,LI Lu,WU Ying-yu,et al..Analysis of Long-Time Efficacy Valve Replacement for Rheumatic Heart Disease[J].Chinese Circulation Journal,2006,21(2):140-142.
Authors:CHU Yan-lin  LI Lu  WU Ying-yu  
Abstract:Objective:To analyze late effect and factors influencing late effect after valve replacement for rheumatic heart disease. Methods:From January 1980 to December2004,valve replacement were performed in613 patients with rheumatic heart disease. There was 30 early deaths 495 were followed-up for,2700 patient-years, with the mean follow-up time was 5. 45%patient-years. Results: There were 37 late deaths,with the death rate of 1.40% (patient-years). The 15-year actual survival rates were 89. 3% and 43. 1% ,and the late death rates were 1. 10% and 6. 1% (patient-years)for mechanical and bioprosthetic valves,respectively. Conclusion:Factors influencing late effect were anticoagulatin-related complications, preoperative cardiac function, age and arterial fibrillation. Late death for mechanical valve replacement were associated with anticoagulation-related copmlications, ventricular arrhythmias,bacterial endocarditis and cardiac failure,but for bioprosthetic valves were due to wear-out failure.
Keywords:Rheumatic cardiac disease  Late efficary  Valve replacement  
本文献已被 CNKI 万方数据 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号